Ivan Horak

Dr. Ivan D.
Horak, MD, is a Chief Executive Officer & Director at Tikva Allocell Pte Ltd., a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology, Inc., a Member at American Society of Hematology and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at Tikva Allocell Pte Ltd. Dr. Horak was previously employed as a Chief Medical & Scientific Officer by Tessa Therapeutics Ltd, a Chief Scientific Officer by Enzon Pharmaceuticals, Inc., a Chief Scientific Officer & Executive VP by Immunomedics, Inc., a Vice President-Clinical Oncology by Pharmacia Corp., a Director-Oncology Clinical Research & Development by The Janssen Research Foundation, a Principal by American College of Physicians, Inc. /Old/, and a Member by Union for International Cancer Control.
He received his doctorate degree from the University of Commenius.